For Australian healthcare readers, GLP-1s are now an access, policy, supply, affordability, and real-world persistence problem
Documentation requirements are extensive: every compounded semaglutide prescription must include the patient's name, prescriber information, specific formulation details, lot numbers of ingredients used, pharmacist signature, and expiration dating
Plant Physiol., 25: 251-260
Originally approved as a type 2 diabetes treatment, aggressive advertisements that promoted Ozempic (semaglutide) weight loss benefits has led to it increasingly being prescribed as a diet drug, which eventually resulted in a weight loss-specific version, Wegovy, also manufactured by Novo Nordisk
Yet the primary issue extends beyond ingredients, it's about digestion mechanics